BIOMATRIX SCIENCES, INC. Competitors

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

STEMCELL Technologies is a Canadian biotechnology company that helps power leading-edge life science research around the world. Driven by our love of science and passion for quality, we are Scientists Helping Scientists—standing by our customers to provide the outstanding products, technical support, and training they need to advance their research. Scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research are among those who rely on our cell culture media, cell separation products, instruments, accessory products, and services. Since the launch of the company by Dr. Allen Eaves in 1993, STEMCELL has reinvested all profits back into the research and development of products to better support the international research community. Today, STEMCELL is the largest biotech company in Canada, with over 2000 employees globally, most with scientific or engineering degrees. Through our many regional offices, as well as our distribution centers in Vancouver, Seattle, Grenoble, and Singapore, we deliver our innovative, specialized products to more than 70 countries. At STEMCELL, we are dedicated to improving lives through advancing knowledge and scientific discovery, through our commitment to fostering diversity and inclusion in STEM and the life sciences industry, and through our investments in sustainability, community, and social responsibility. We do all this because we love science as much as you do. #ScientistsHelpingScientists

BioTissue® is a pioneer & proven industry leader in eye care, harnessing the unique power of human birth tissue to support regenerative therapies for Ocular Surface Disease (OSD). Our portfolio of Cryopreserved Amniotic Membrane (CAM) products, including CAM360 AmnioGraft™, Prokera®, AmnioGraft®, and AmnioGuard®, use our proprietary CryoTek® cryopreservation technology, designed to retain the tissue’s structural & functional integrity. CAM is the only Amniotic Membrane recognized by the FDA for anti-inflammation, anti-scarring, and anti- angiogenesis.1 Eye doctors use CAM360 AmnioGraft & Prokera biologic corneal bandage devices to treat ocular conditions including Neurotrophic Keratitis (NK), Persistent Epithelial Defects (PEDs), and many other Ocular Surface Diseases (OSDs). AmnioGraft can be used for surgical applications ranging from treating burns, primary & recurring pterygiums, and ocular surface reconstruction. AmnioGuard, derived from the umbilical cord, is commonly used by oculoplastic & glaucoma surgeons to provide tectonic support for treating corneal, scleral, socket, fornix, and eyelid cases. BioTissue is committed to empowering healthcare professionals with solutions to deliver optimal patient outcomes by fostering innovation through evidence-based science. Since its inception, clinicians have performed over 1 million human implants using CAM products and published 440 peer-reviewed publications supporting BioTissue’s platform technology.